Position in GILD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$322,016,474
+$224,636,400 QoQ
Shares Held
2,310,515
+191.2% QoQ
Ownership
0.186%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Dec 31, 2025CallValue
$24,548
CallShares
200
PutValue
$12,274
PutShares
100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MARSHALL WACE, LLP holds $2,860,542,672 across 13 Drug Manufacturers - General names. GILD ranks #5 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
2,377,822 | $581,234,808 | |
| 2 | LLY |
ELI LILLY & Co
|
576,174 | $529,947,557 | |
| 3 | PFE |
Pfizer Inc
|
16,082,788 | $451,604,686 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,778,301 | $334,201,827 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
2,310,515 | $322,016,474 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
3,689,838 | $223,788,674 | |
| 7 | NVO |
Novo Nordisk A S
|
3,046,611 | $111,962,952 | |
| 8 | AMGN |
Amgen Inc
|
316,917 | $111,507,246 |
All Filings in GILD
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $322,016,474 | 2,310,515 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $97,380,074 | 793,385 | Shares | Other | 2026-02-13 | |
| 2025-12-31 | $12,274 | 100 | Put | Other | 2026-02-13 | |
| 2025-12-31 | $24,548 | 200 | Call | Other | 2026-02-13 | |
| 2025-09-30 | $11,100 | 100 | Put | Other | 2025-11-13 | |
| 2025-09-30 | $211,064,280 | 1,901,480 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $216,286,637 | 1,950,813 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $86,711,796 | 773,867 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $112,395,630 | 1,216,798 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $85,824,073 | 1,023,665 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $8,268,602 | 120,516 | Shares | Other | 2024-08-14 | |
| 2023-06-30 | $3,020,373 | 39,190 | Shares | Other | 2023-08-14 | |
| 2023-06-30 | $9,803,304 | 127,200 | Call | Other | 2023-08-14 | |
| 2023-06-30 | $14,735,784 | 191,200 | Put | Other | 2023-08-14 | |
| 2023-03-31 | $421,039,727 | 5,074,602 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $380,309,489 | 4,429,930 | Shares | Other | 2023-02-14 | |
| 2022-12-31 | $3,210,790 | 37,400 | Put | Other | 2023-02-14 | |
| 2022-12-31 | $5,863,555 | 68,300 | Call | Other | 2023-02-14 | |
| 2022-09-30 | $3,880,301 | 62,900 | Call | Other | 2022-11-14 | |
| 2022-09-30 | $207,583,332 | 3,364,943 | Shares | Other | 2022-11-14 | |
| 2022-09-30 | $2,122,136 | 34,400 | Put | Other | 2022-11-14 | |
| 2022-06-30 | $184,407,044 | 2,983,450 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $148,056,597 | 2,490,439 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $4,327,556 | 59,600 | Put | Other | 2022-02-14 | |
| 2021-12-31 | $14,885,050 | 205,000 | Call | Other | 2022-02-14 | |
| 2021-12-31 | $2,024,657 | 27,884 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $7,355,205 | 105,300 | Put | Sole | 2021-11-15 | |
| 2021-09-30 | $670,560 | 9,600 | Shares | Sole | 2021-11-15 | |
| 2021-09-30 | $20,878,165 | 298,900 | Call | Sole | 2021-11-15 | |
| 2021-03-31 | $3,131,905 | 48,459 | Shares | Sole | 2021-05-17 | |
| 2021-03-31 | $2,591,663 | 40,100 | Call | Sole | 2021-05-17 | |
| 2020-12-31 | $5,204,132 | 89,326 | Shares | Sole | 2021-02-16 | |
| 2020-03-31 | $284,013 | 3,799 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||